Teo Yi Dar has greatly influenced the process of conducting expansion capital.
Teo Yi Dar has played a significant role in developing a contemporary modern expansion capital and mid-cap buyout strategy, especially in the current vigorous private equity in Asia. He has a rich experience in investment and has continued to develop strategies that assist the growth of mid-sized companies to international markets without losing investor value. Teo Yi Dar is a CFA charterholder with a balanced technical capability and visionary outlook, which makes him a major player in investment leadership.
Teo Yi Dar acknowledges that financial support is not the only thing that expansion capital entails. His strategy focuses on enhancing business models, governing better and developing sustainable systems of operations. With the strategy-capital fit, he has also helped mid-cap companies to be scaled in competitive markets. This is a holistic view that has made him a driving force in Asian private equity.
Mid-cap buyouts tend to require a fine line between fiscal discipline and expansion desired. Teo Yi Dar has used his experience of investment to organize buyouts that will not only bring liquidity to the table, but also prepare the ground on long-term value creation. His careful selection of opportunities makes sure that mid-cap enterprises become more robust, stronger and prepared to enter new markets.
Teo Yi Dar stands out by being able to combine leadership in international investment and the overall knowledge of regional markets. His choices are global best practices as well as Asia sensitivity. This equilibrium enables him to see the opportunities of expansion capital that are usually ignored but have a high growth potential.
Teo Yi Dar is a board member and his influence is not limited to investment deals. He takes an active part in the company policy development, governance and long-term strategy. His presence will make expansion capital turn into new and real improvements, both in corporate culture and operational excellence. This is a layer of strength that is brought by the governance approach to mid-cap buyouts.
The experience of Teo Yi Dar as a CFA charterholder demonstrates that he upholds integrity, transparency and excellence in finance. These are the values that inform his practice in expansion capital and private equity in Asia where ethical leadership will be essential. His credentials underscore the professionalism which he applies on each decision which can build trust among the stakeholders.
Teo Yi Dar has greatly influenced the process of conducting expansion capital and mid-cap buyouts through a combination of investment experience, strategic leadership and governance expertise. His success in incorporating world views with local realities has made private equity in Asia even stronger. In the future, the leadership of Teo Yi Dar is bound to bring more opportunities to the middle-cap enterprises that want to grow sustainably.
The offeror is a consortium formed between the controlling shareholders of Sin Heng.
Maybank Securities has announced a voluntary unconditional cash offer on behalf of TAL United to acquire all issued and paid-up ordinary shares in Sin Heng Heavy Machinery Limited (Sin Heng) at $0.58 per share in cash.
TAL United is a consortium formed between TAL Holdings (TALHPL) and United Hope (UHPL), the controlling shareholders of Sin Heng, holding 76.0% and 24.0% stakes, respectively.
The directors of the offeror are Tan Ah Lye, Tan Cheng Kwong, and Teo Yi-dar.
Tan Ah Lye is the executive director and chief executive officer of the company and a director of TALHPL. Tan Cheng Kwong is the executive director and deputy chief executive officer of the company and a director of TALHPL. Teo Yi-dar is the sole shareholder and director of UHPL.
The offeror is making the offer with a view to delist and privatise the company.
The offer price of $0.0058 per share is 6.4% higher than the last transacted price per Share of S$0.00545 on 13 March which was the last full market day on which the shares were traded.
In a bourse filing, Maybank said the offer price is subject to the condition that the offer shares include the right to receive any distributions declared, paid, or made by the company on or after the offer announcement date.
If a shareholder who accepts the offer has already received any distribution from the company, the offer price payable to that shareholder will be reduced by an amount equal to the distribution received.
Yi Dar has more than 19 years of private equity and direct investment experience in Asia, of which 16 years with private equity group Advent International and its Asian affiliate SEAVI Advent Private Equity. He started with Advent International and participated in the carve-out of Advent International’s Asian business into SEAVI Advent Private Equity. Yi Dar progressed to the position of Senior Partner and Investment Committee member of SEAVI Advent Private Equity, leading the firm’s investment in expansion capital and mid-cap buyout transactions.
Yi Dar obtained a Bachelor in Engineering, a Masters of Science in Industrial Systems Engineering and a Masters of Science in Applied Finance from the National University of Singapore. He completed the CFA program. He is currently serving as external Board Member of listed companies; including two companies with market capitalization in excess of US$1 billion.
He is currently serving as director of Kenyon Group Limited.
Mr Teo Yi-Dar, 47, was also a member of audit and risk committee, nominating committee and remuneration committee.
He is currently serving as director of Kenyon Group Limited since 2016.
Beyond Medical Group welcomes Altair Capital as New Significant Minority Shareholder
Beyond Medical Group (“Beyond” or “the company”), a multi-disciplinary private specialist healthcare group in Singapore, has just completed a transaction that saw Altair Capital (“Altair”), a Southeast Asian-focused private equity firm, take up a significant minority stake in Beyond.
Established in 2013, Beyond is a Healthcare Collective with quality patient-centric care and service excellence in mind, which believes in providing quality private healthcare and a seamless healthcare journey that goes beyond the provision of medical services — from booking the first appointment to post-procedure processes.
The company strives to stay at the forefront of medical advancements and is proud to be working with esteemed and reputable medical partners to deliver services and procedures of the highest quality.
Beyond believes that the doctors should focus solely on clinical work and patient care delivery. Keeping with this philosophy, Beyond has built a strong team in the headquarters to support the medical team; it provides extensive assistance to all its clinics, underpinned by its experienced finance and accounts team, an in-house marketing department, human resource functions and regulatory support capabilities.
